AL
MNA icon

Aspiriant LLC’s NYLIM Merger Arbitrage ETF MNA Stock Holding History

Aspiriant LLC’s Portfolio MNA Stock Details MNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.64M Buy
181,887
+11,672
+7% +$425K 0.16% 62
2026
Q1 		$6.19M Buy
170,215
+18,548
+12% +$671K 0.18% 61
2025
Q4 		$5.43M Buy
151,667
+10,009
+7% +$359K 0.16% 68
2025
Q3 		$5.09M Buy
141,658
+9,979
+8% +$355K 0.16% 63
2025
Q2 		$4.64M Buy
131,679
+6,032
+5% +$209K 0.15% 65
2025
Q1 		$4.31M Buy
125,647
+19,110
+18% +$643K 0.15% 60
2024
Q4 		$3.51M Sell
106,537
-11,222
-10% -$369K 0.13% 67
2024
Q3 		$3.87M Buy
117,759
+1,903
+2% +$61.7K 0.15% 63
2024
Q2 		$3.66M Sell
115,856
-19,825
-15% -$617K 0.15% 64
2024
Q1 		$4.27M Sell
135,681
-27,241
-17% -$854K 0.18% 58
2023
Q4 		$5.12M Sell
162,922
-33,285
-17% -$1.04M 0.23% 51
2023
Q3 		$6.2M Buy
196,207
+13,694
+8% +$430K 0.32% 45
2023
Q2 		$5.69M Buy
182,513
+16,983
+10% +$534K 0.29% 47
2023
Q1 		$5.24M Sell
165,530
-66,010
-29% -$2.07M 0.27% 51
2022
Q4 		$7.35M Sell
231,540
-636,036
-73% -$20M 0.37% 37
2022
Q3 		$27.1M Buy
867,576
+227,755
+36% +$7.2M 1.33% 20
2022
Q2 		$19.8M Buy
639,821
+578,376
+941% +$18.2M 0.96% 19
2022
Q1 		$1.96M Buy
61,445
+9,130
+17% +$291K 0.11% 89
2021
Q4 		$1.69M Buy
52,315
+19,021
+57% +$619K 0.09% 96
2021
Q3 		$1.1M Buy
33,294
+3,943
+13% +$131K 0.06% 113
2021
Q2 		$983K Buy
+29,351
New +$981K 0.06% 116

Other funds holding MNA

NYLIM
New York Life Investment Management New York $14.3B AUM 34.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
OPCM
Osborne Partners Capital Management San Francisco, California $1.8B AUM 22.23% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return
EH
Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $34.1B AUM 22.4% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Aspiriant LLC's MNA Position: Q2 2026 in Review

Aspiriant LLC increased its NYLIM Merger Arbitrage ETF (MNA) stake by 6.9% in Q2 2026, buying an estimated $425K and bringing the position to 181,887 shares worth $6.64M. The position accounts for 0.16% of the portfolio, ranked #62.

Aspiriant LLC first reported a position in MNA in Q2 2021 and has held it in 21 quarters since. The position peaked at $27.1M in Q3 2022. 83 funds tracked by Wall St. Rank hold MNA as of Q2 2026.

  • Aspiriant LLC held 181,887 shares of NYLIM Merger Arbitrage ETF worth $6.64M as of Q2 2026.
  • Aspiriant LLC bought 11,672 NYLIM Merger Arbitrage ETF shares in Q2 2026, an estimated $425K.
  • NYLIM Merger Arbitrage ETF made up 0.16% of Aspiriant LLC's portfolio in Q2 2026, its #62 holding.
  • Aspiriant LLC first reported a position in NYLIM Merger Arbitrage ETF in Q2 2021 and has held it in 21 quarters since.
  • Aspiriant LLC's NYLIM Merger Arbitrage ETF position peaked at $27.1M in Q3 2022.
  • 83 funds tracked by Wall St. Rank held NYLIM Merger Arbitrage ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.